
1001 - 5000 employees
Founded 1991
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
Healthcare • Biotechnology • Pharmaceuticals
Sobi - Swedish Orphan Biovitrum AB (publ) is a global leader in providing innovative treatments for people with rare diseases. Specializing in therapeutic areas such as haematology and immunology, Sobi is committed to improving patient access to medicines for rare and debilitating conditions. With a strong R&D pipeline, the company is actively pursuing new therapies and collaborating globally to transform patient care in areas such as haemophilia and immune thrombocytopenia. Sobi also engages in extensive sustainability and humanitarian aid programs, demonstrating a firm commitment to patient-centric care and societal contributions.
Selected: 🇬🇧 United Kingdom – Remote (UK).
Selected: 🆕 Date Added.
🕒 October 6
Regional medical excellence leader advancing rare-disease therapies across Europe for Sobi, a specialty biopharmaceutical company. Driving medical strategy, launch readiness, stakeholder engagement, and team capability.
🕒 October 6
Regional medical excellence leader advancing medical strategy, launch readiness, and stakeholder partnerships for Sobi’s rare-disease therapies across Europe.
🕒 October 2
Global Product Safety Science Lead owning safety surveillance and benefit-risk strategy for Sobi’s rare-disease medicines. Leading regulatory deliverables, cross-functional development teams and global pharmacovigilance collaboration.
🕒 June 30
Lead safety science for product lifecycle within Sobi, focusing on pharmacovigilance and product safety. Collaborating with global teams, driving safety strategies and risk management for rare disease treatments.
🕒 May 23
Senior Manager, Market Access supporting launch strategies for specialty care products. Collaborating with cross-functional teams in an international pharmaceutical company.